TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer

By sjmartinez • January 3, 2025

Abelman RO, Wu B, Barnes H, Medford A, Norden B, Putur A, Bitman E, Thant W, Liu T, Weipert C, Fell G, Spring LM, Wander S, Moy B, Vidula N, Isakoff SJ, Varkaris A, Juric D, Corcoran R, Ellisen LW, Bardia A. TOP1 Mutations and Cross-Resistance to Antibody-Drug Conjugates in Patients with Metastatic Breast Cancer. Clin Cancer Res. 2025 Jan 2. doi: 10.1158/1078-0432.CCR-24-2771. Epub ahead of print. PMID: 39745368.

Tags: General Internal Medicine, Hematology/Oncology, Publications

Quantitative 3-T Multiparametric MRI Parameters as Predictors of Aggressive Prostate Cancer

Kim DHS, Sonni I, Grogan T, Sisk A, Murthy V, Hsu W, Sung K, Lu DS, Reiter RE, Raman SS. Quantitative 3-T Multiparametric MRI Parameters[...]

Low- and High-Volume Disease in Metastatic Hormone-Sensitive Prostate Cancer: From CHAARTED to PSMA PET-An International Multicenter Retrospective Study

Unterrainer LM, Hope TA, Fendler WP, Grogan T, Ndlovu H, Armstrong W, Barbato F, Benz MR, Rettig MB, Kishan AU, Sathekge M, Herrmann K, Czernin[...]

Sex Differences, Menses-Related Symptoms and Menopause in Disorders of Gut-Brain Interaction

Sarnoff RP, Hreinsson JP, Kim J, Sperber AD, Palsson OS, Bangdiwala SI, Chang L. Sex Differences, Menses-Related Symptoms and Menopause in Disorders of Gut-Brain Interaction.[...]